During the past decade, OSF Healthcare conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 2 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 2 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "OSF Healthcare" are "Compassion Fatigue" (1 trials), "Diabetes Mellitus" (1 trials), "Heart Failure NYHA Class III" (1 trials), "Heart Failure With Preserved Ejection Fraction" (1 trials) and "Hypertension" (1 trials). Many other conditions were trialed in "OSF Healthcare" in a lesser frequency.

Most popular intervention types in "OSF Healthcare" are "Device" (2 trials), "Drug" (2 trials), "Behavioral" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Oral treprostinil" (2 trials), "Cordella™ Pulmonary Artery Sensor System" (1 trials), "Educational Intervention" (1 trials), "Lungpacer Diaphragm Pacing Therapy" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "OSF Healthcare" are 6 trials for "All" genders.

Currently, there are NaN active trials in "OSF Healthcare". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in OSF Healthcare, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in OSF Healthcare, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".